These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 5561918)

  • 1. [The dynamics of partial renal function in renal tuberculosis during treatment with single daily doses of antitubercular drugs].
    Khachanov RM
    Probl Tuberk; 1971; 49(2):42-5. PubMed ID: 5561918
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of patients with renal tuberculosis by intravenous administration of antitubercular drugs].
    Gushanskiĭ AM
    Probl Tuberk; 1973; 51(2):42-4. PubMed ID: 4772477
    [No Abstract]   [Full Text] [Related]  

  • 3. [Efficacy of various chemotherapeutic regimens in renal tuberculosis].
    Danilova NK; Mochalova TP; Gur'ia IE
    Vrach Delo; 1981 Nov; (11):86-9. PubMed ID: 7342451
    [No Abstract]   [Full Text] [Related]  

  • 4. Tuberculosis of the remaining kidney. Renal function after long-term chemotherapy.
    Fritjofsson A; Helander CG; Lindell SE; Obrant O
    Acta Chir Scand; 1965 Oct; 130(4):287-98. PubMed ID: 5842501
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chemotherapy of renal tuberculosis].
    Mazurek LJ
    Pneumonol Pol; 1985 Jan; 53(1):15-8. PubMed ID: 4011451
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapeutic tactics in patients with tuberculosis of the urinary system and allergy to antitubercular drugs].
    Stepanov PI
    Probl Tuberk; 1986; (3):44-7. PubMed ID: 2940590
    [No Abstract]   [Full Text] [Related]  

  • 7. [Capreomycin serum level in patients with urogenital tuberculosis with impaired renal function].
    König K; Gundlach G; May P; Jochum K
    Urologe; 1969; 8(1):20-5. PubMed ID: 5359364
    [No Abstract]   [Full Text] [Related]  

  • 8. [Development of fibroplastic processes during various methods of treating experimental cavernous tuberculosis of the single kidney].
    Mazaev MB
    Probl Tuberk; 1981 Jan; (1):61-4. PubMed ID: 7208469
    [No Abstract]   [Full Text] [Related]  

  • 9. [Administration of antituberculous drugs to subjects with basic diseases. 1. Chemotherapy of tuberculosis in patients with impaired renal function].
    Usuta Y
    Kekkaku; 1987 Dec; 62(12):664-7. PubMed ID: 3448351
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of intravenous administration of 1st series preparations on blood coagulation in pulmonary and renal tuberculosis].
    Radkevich RA; Utkin VV; Gushanskiĭ AM
    Probl Tuberk; 1970; 48(7):31-5. PubMed ID: 5486078
    [No Abstract]   [Full Text] [Related]  

  • 11. [Determination of glomerular filtration with the aid of Y6169-DTPA in patients with tuberculosis of a solitary kidney].
    Gorovenko VI
    Probl Tuberk; 1974; (11):47-50. PubMed ID: 4449842
    [No Abstract]   [Full Text] [Related]  

  • 12. [Direct endolymphatic administration of antitubercular drugs in patients with inflammatory diseases of the urogenital organs].
    Mochalova TP; Shapiro AL; Dubinin MI; Polinov AV; Poliachenko AP
    Probl Tuberk; 1989; (2):40-2. PubMed ID: 2704711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Function and morphology of the kidney in acute kidney failure].
    Bohle A; Thurau K
    Verh Dtsch Ges Inn Med; 1974; 80():565-82. PubMed ID: 4454625
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of uremic environment on renal concentrating and diluting mechanisms in a severely damaged nephron population.
    Morrin PA; Joynt SK; Handa SP; Frame J
    Invest Urol; 1970 Nov; 8(3):273-83. PubMed ID: 5486827
    [No Abstract]   [Full Text] [Related]  

  • 15. [Laser therapy in renal tuberculosis: mechanism of action].
    Kul'chavenia EV
    Probl Tuberk; 1995; (2):11-3. PubMed ID: 7777451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the type of tubazid inactivation in nephrotuberculosis with chronic kidney failure].
    Tkachuk VN; Titarenko OT; Vakhmistrova TI; Perova TL
    Urol Nefrol (Mosk); 1981; (6):33-6. PubMed ID: 7314312
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative evaluation of therapeutic effects of 3 and 4 antitubercular agents at the initial stage of the treatment of renal tuberculosis].
    Kamyshan IS; Pavlova LP; Mams AN; Saĭdakova NA; Stepanov PI
    Probl Tuberk Bolezn Legk; 2004; (10):15-9. PubMed ID: 15568312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal function damage in 131 cases of urogenital tuberculosis.
    Wisnia LG; Kukolj S; Lopez de Santa Maria J; Camuzzi F
    Urology; 1978 May; 11(5):457-61. PubMed ID: 675900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Kidney and tuberculosis: present aspects of medical therapy in renal tuberculosis and in nephropathic conditions secondary to or associated with tuberculosis in other areas of the body (except the kidney)].
    De Simoni G
    Ann Ist Carlo Forlanini; 1968; 28(3):218-46. PubMed ID: 5738648
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of renal tuberculosis in persons who poorly tolerate antitubercular agents].
    Grund VD; Gushanskiĭ AM
    Urol Nefrol (Mosk); 1971; 36(2):34-7. PubMed ID: 5142454
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.